Clonal Hematopoiesis of Indeterminate Potential and Cardiometabolic Disease: Challenges, Controversies and Future Perspectives

Ioanna A. Anastasiou, Dimitris Kounatidis, Natalia G. Vallianou, Eleni Rebelos, Irene Karampela, Maria Dalamaga · 2025

Read Clonal Hematopoiesis of Indeterminate Potential and Cardiometabolic Disease: Challenges, Controversies and Future Perspectives by Ioanna A. Anastasiou, Dimitris Kounatidis, Natalia G. Vallianou, Eleni Rebelos, Irene Karampela, Maria Dalamaga (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12785648.txt.

Description

Ioanna Anastasiou and co-authors review in this 2025 paper a blood condition called CHIP, short for clonal hematopoiesis of indeterminate potential. In CHIP, a blood stem cell with a mutation grows into a large clone, yet no blood cancer is present. The state is common with age and shows in more than a fifth of people over eighty.

The review links CHIP to heart and metabolic disease, not just cancer risk. Carriers face notably higher rates of heart events and death, and mouse work ties some mutations to vessel swelling and clots. The authors weigh screening limits and new drug ideas, and frame CHIP as a risk factor that care may one day treat.

Catalog record

CREATORIoanna A. Anastasiou, Dimitris Kounatidis, Natalia G. Vallianou, Eleni Rebelos, Irene Karampela, Maria Dalamaga
YEAR2025
COLLECTIONPAPERS
FORMATTXT
FILE SIZE80 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC12785648

Browse the full library · About the Tower of Babel